Tag: CBD-
Cannabis Use Disorder Linked to Perioperative Complications
Increase seen in in-hospital mortality and seven perioperative complications for adults undergoing major elective inpatient surgery
FDA Sends Warning to Companies Selling THC Products That Look Like Candy, Cookies
Delta-8 THC has psychoactive and intoxicating effects, and has not been evaluated or approved by the FDA for safe use in any context
Medical Cannabis Laws Seem Not to Have Affected Opioid, Nonopioid Therapy
No impact on receipt of opioid or nonopioid pain treatment seen among patients with chronic noncancer pain
Legalization of Nonmedical Cannabis Tied to More Acute Care Visits During Pregnancy
Rate of acute care related to cannabis use during pregnancy increased from 11.0 to 20.0 per 100,000 pregnancies from before versus after legalization
Medical Cannabis Tied to Improved Health-Related Quality of Life
Improvement observed across a range of health conditions, mostly sustained over time
One in Four Young Male Cases of Schizophrenia Could Be Prevented
Overall risk of CUD on schizophrenia was slightly higher among men than women
Medical Cannabis Effective for Pain Relief in Cancer
Pain relief better with THC:CBD balanced strains than THC-dominant and CBD-dominant strains
Most Melatonin Gummies Have Inaccurate Labels
Analysis shows most exceed the declared amount of melatonin and cannabidiol and may expose children to very high doses
Intentional, Suspected Suicidal Cannabis Exposures Increased From 2009 to 2021
However, most cases involved more than one substance
Cannabidiol Oil No Benefit After Ureteroscopy With Stent Placement
Cannabidiol oil does not reduce pain or opioid use for patients undergoing ureteroscopy with stent placement for urinary stones
